We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£520.00
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 3 months
US Lung Cancer Screening Software Outlook 2023-2028 Study
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 87 days · 87 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 87 days • 1 price levels
Price Analysis
Most common price: £520 (87 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 87 days
Description
Key Features
Provides latent demand outlooks for lung cancer screening software in the United States through 2028.
Includes potential industry earnings (P.I.E.) estimates across approximately 12,600 cities.
Offers comparative benchmarks showing a city's percent share of its state and the entire country.
Supports distribution and sales force strategies through detailed geographic market data.
Uses an econometric approach to analyze market demand in millions of U.S. dollars.
Product Specifications
- Format
- paperback
- ASIN
- B0BLQWKLM4
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
India Lung Cancer Screening Software Outlook 2023-2028
The 2023-2028 Outlook for Lung Cancer Screening Software in China
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
The 2023-2028 Outlook for Lung Cancer Screening Software in Japan
The 2023-2028 World Outlook for Lung Cancer Screening Software
Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2021-2026 World Outlook for Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
Lung Cancer Screening Software Outlook 2023-2028 Report
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
2023-2028 US Cancer Screening Outlook - Market Study
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
The 2023-2028 World Outlook for Non-Small Cell Lung Cancers
Price unavailable
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
